Treatment of acute intracerebral hemorrhage

Current Treatment Options in Neurology

Volumn 10, Issue 6, 2008, Pages 455-467

  Demaerschalk, Bart M ^a   Aguilar, Maria I ^a  

^a MAYO CLINIC HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; ENALAPRIL; ESMOLOL; FIBRINOLYTIC AGENT; FOSPHENYTOIN SODIUM; FRESH FROZEN PLASMA; FUROSEMIDE; HEPARIN; HYDRALAZINE; INSULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; METOPROLOL; NEUROPROTECTIVE AGENT; NICARDIPINE; NITROPRUSSIDE SODIUM; PARACETAMOL; PLACEBO; PROTAMINE SULFATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; UROKINASE; VITAMIN K GROUP; WARFARIN;

ABDOMINAL PAIN; ACUTE DISEASE; AGITATION; AGRANULOCYTOSIS; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ANOREXIA; ARTERY THROMBOSIS; ASTHENIA; BLOOD CLOTTING DISORDER; BRADYCARDIA; BRAIN HEMORRHAGE; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPRESSION THERAPY; CONFUSION; CONSTIPATION; CONTINUOUS INFUSION; COUGHING; CREATININE BLOOD LEVEL; DECOMPRESSION SURGERY; DEEP VEIN THROMBOSIS; DIAPHORESIS; DIARRHEA; DIET RESTRICTION; DIZZINESS; DOSE RESPONSE; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSPNEA; EDEMA; EJACULATION DISORDER; FATIGUE; FRAMELESS STEREOTACTIC PROCEDURE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; ILEUS; IMPOTENCE; INDIGESTION; INJECTION SITE PAIN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; KIDNEY DISEASE; KIDNEY FAILURE; LEUKOPENIA; LIFESTYLE MODIFICATION; LIVER FAILURE; LIVER TOXICITY; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EDEMA; LUNG EMBOLISM; NAUSEA; NAUSEA AND VOMITING; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NEUROSURGERY; NONHUMAN; NOSE CONGESTION; OPTIMAL DRUG DOSE; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PNEUMONIA; PROGNOSIS; PRURITUS; REHABILITATION CARE; REPRODUCTIVE TOXICITY; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SYNCOPE; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; TASTE; THERAPEUTIC HYPERVENTILATION; THORAX PAIN; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UREA BLOOD LEVEL; VOMITING; WHEEZING;

EID: 58849094108     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0048-3     Document Type: Review

References (55)

1. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD: Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994, 57: 936-940.
2. Broderick JP, Brott T, Tomsick T, et al.: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993, 78: 188-191.
3. Counsell C, Boonyakarnkul S, Dennis M, et al.: Primary intracerebral haemorrhage in the Oxfordshire Community Stroke project, 2: Prognosis. Cerebrovasc Dis 1995, 5:26-34.
4. Flaherty ML, Woo D, Haverbusch M, et al.: Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005, 36:934-937.
5. Flaherty ML, Haverbusch M, Sekar P, et al.: Long-term mortality after intracerebral hemorrhage. Neurology 2006, 66:1182-1186.
6. Goldstein LB, Simel DL: Is this patient having a stroke? JAMA 2005, 293:2391-2402.
7. Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007, 38: 2001-2023.
8. Aguilar MI, Demaerschalk BM: Intracerebral hemorrhage. Semin Neurol 2007, 27:376-384.
9. Freeman WD, Brott TG: Modern treatment options for intracerebral hemorrhage. Curr Treat Options Neurol 2006, 8:145-157.
10. Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF: Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 2005, 80:420-433.
11. Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group, Cardiovascular Nursing Council, Clinical Cardiology Council, Nutrition, Physical Activity, and Metabolism Council, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke 2006, 37: 1583-1633. (Published erratum appears in Stroke 2007, 38: 207.)
12. Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352: 777-785.
13. Mayer SA, Brun NC, Begtrup K, et al.: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127-2137.
14. Brody DL, Aiyagari V, Shackleford AM, Diringer MN: Use of recombinant factor VIIa in patients with warfarinassociated intracranial hemorrhage. Neurocrit Care 2005, 2:263-267.
15. Flaherty ML, Kissela B, Woo D, et al.: The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007, 68: 116-121.
16. Aguilar MI, Hart RG, Kase CS, et al.: Treatment of warfarinassociated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc 2007, 82:82-92.
17. Levine JM, Snider R, Finkelstein D, et al.: Early edema in warfarin-related intracerebral hemorrhage. Neurocrit Care 2007, 7:58-63.
18. Xi G, Keep RF, Hoff JT: Pathophysiology of brain edema formation. Neurosurg Clin North Am 2002, 13:371-383.
19. Sjoblom L, Hardemark HG, Lindgren A, et al.: Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke 2001, 32: 2567-2574.
20. Berwaerts J, Robb OJ, Jeffers TA, Webster J: Intracerebral haemorrhages and oral anticoagulation in the north of Scotland. Scott Med J 2000, 45:101-104.
21. Flibotte JJ, Hagan N, O'Donnell J, et al.: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004, 63:1059-1064.
22. Yasaka M, Minematsu K, Naritomi H, et al.: Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 2003, 89:278-283.
23. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
24. Derex L, Hermier M, Adeleine P, et al.: Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005, 76:70-75.
25. Demchuk AM, Morgenstern LB, Krieger DW, et al.: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34-39.
26. Mahaffey KW, Granger CB, Sloan MA, et al.: Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: Results from GUSTO-I. Circulation 1998, 97:757-764.
27. Warach S, Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004, 35:2659-2661.
28. Gebel JM, Brott TG, Sila CA, et al.: Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000, 31:596-600.
29. Mahaffey KW, Granger CB, Sloan MA, et al.: Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue-plasminogen activator (tPA) for Occluded coronary arteries. Am Heart J 1999, 138:493-499.
30. Misra UK, Kalita J, Ranjan P, Mandal SK: Mannitol in intracerebral hemorrhage: A randomized controlled study. J Neurol Sci 2005, 234:41-45.
31. Cruz J, Minoja G, Okuchi K: Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: A randomized trial. Neurosurgery 2002, 51: 628-637; discussion 637-628.
32. Freeman WD, Brott TG, Barrett KM, et al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004, 79:1495-1500.
33. Suarez JI, Qureshi AI, Bhardwaj A, et al.: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998, 26:1118-1122.
34. Steiner T, Diringer MN, Schneider D, et al.: Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: Risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006, 59: 767-773; discussion 773-774.
35. Sugg RM, Gonzales NR, Matherne DE, et al.: Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006, 67:1053-1055.
36. Fernandes HM, Gregson B, Siddique S, Mendelow AD: Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000, 31:2511-2516.
37. Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005, 365:387-397.
38. STICH II Trial. http://www.ncl.ac.uk/stich/. Accessed August 18, 2008.
39. Morioka J, Fujii M, Kato S, et al.: Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol 2006, 65: 67-72; discussion 72-73.
40. Da Pian R, Bazzan A, Pasqualin A: Surgical versus medical treatment of spontaneous posterior fossa haematomas: A cooperative study on 205 cases. Neurol Res 1984, 6:145-151.
41. Firsching R, HuberMM, Frowein RA: Cerebellar haemorrhage: management and prognosis. Neurosurg Rev 1991, 14: 191-194.
42. van Loon J, Van Calenbergh F, Goffin J, Plets C: Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 49 cases and review of the literature. Acta Neurochir (Wien) 1993, 122:187-193.
43. Nishihara T, Nagata K, Tanaka S, et al.: Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit Care 2005, 2:67-74.
44. Vespa P, McArthur D, Miller C, et al.: Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care 2005, 2:274-281.
45. Murthy JM, Chowdary GV, Murthy TV, et al.: Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocrit Care 2005, 2:258-262.
46. Hanley D, Hacke W: Critical care and emergency medicine neurology in stroke. Stroke 2005, 36:205-207.
47. Demaerschalk BM: Fibrinolytic therapy for intraventricular hemorrhage: is the answer becoming clear yet? Eur J Neurol 2008, 15:320-322.
48. Powner DJ, Hartwell EA, Hoots WK: Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 2005, 57:823-831.
49. Teernstra OP, Evers SM, Lodder J, et al.: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: A multicenter randomized controlled trial (SICHPA). Stroke 2003, 34:968-974.
50. CLEAR-IVH Trial: Thrombolytic Brain Hemorrhage Study. http://clearivh.com/default.aspx. Accessed August 18, 2008.
51. Hanley D: Final results of CCEAR IVH trial: clot lysis, safety, and functional outcomes [abstract]. Cerebrovasc Dis 2008, 25(Suppl 2):9.
52. Duncan PW, Zorowitz R, Bates B, et al.: Management of adult stroke rehabilitation care: A clinical practice guideline. Stroke 2005, 36:e100-e143.
53. Pluchino S, Martino G: Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain. Brain 2008, 131:604-605.
54. Lyden PD, Shuaib A, Lees KR, et al.: Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: The CHANT Trial. Stroke 2007, 38:2262-2269.
55. Jordan LC, Hillis AE: Hemorrhagic stroke in children. Pediat Neurol 2007, 36:73-80.